Focal therapy cuts prostate cancer side effects. Discover the promising 10-year results and why NHS access remains limited.
Hosted on MSN
Where American men live may shape their odds of surviving prostate cancer, new study reveals
New federal data analyzed by the Daily Mail suggests that where American men live may play a major role in whether they survive prostate cancer, with sharp regional differences emerging in diagnosis ...
About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...
Following almost a decade of decline, prostate cancer incidence in the U.S. increased 3.0% per year between 2014 through 2021, according to a report published Sept. 2 in CA: A Cancer Journal for ...
Please provide your email address to receive an email when new articles are posted on . Improved screening and treatments could reverse global prostate cancer mortality trends. Involving other ...
Prospective registry data describe oncologic outcomes up to 10 years after focal HIFU or cryotherapy for prostate cancer.
Researchers are warning global prostate cancer cases are set to double in a 20-year span. In a new report out in the Lancet, a team of researchers state that in 2020, global prostate cancer cases were ...
Getting screened for prostate cancer may not help you stay alive after all. In a 20-year study of more than 9,000 Swedish men, researchers found no difference in the rate of prostate cancer deaths ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results